This was achieved by analyzing the individual effects of the GSTO1*C419A (rs4925) and GSTO2*A424G (rs156697) polymorphisms on the risk for the development of ovarian cancer by computing logistic regression analysis through a crude model (OR1), and afterwards confirming such findings through an adjusted model (OR2). Here, GSTO2 is linked to ovarian cancer.